Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
20806-43-3
93204-37-6
3005-66-1
145881-74-9
19645-29-5
206265-31-8
13125-63-8 | N-Ethyl-3-phenyl-1-propanamine hydrochloride | AA009JIS | MFCD08559359
1401786-30-8 | 3-(2-Fluorophenoxy)azetidine hydrochloride | AA009K0I | MFCD07774229
1202765-56-7 | 6-Bromo-2',3',5',6'-tetrahydrospiro[indoline-3,4'-pyran] | AA009LSS | MFCD19703314
103999-44-6 | ETHANONE, 2-AMINO-1-(2,3-DICHLOROPHENYL)-, HYDROCHLORIDE | AA009NJN | MFCD09839327
104754-51-0 | 2-(Benzyloxycarbonylamino)-5-oxotetrahydrofuran-2-carboxylic acid | AA009P0X | MFCD00546276
1207-59-6 | 2,5-Dimethoxy-4-nitrobenzaldehyde | AA009QZW | MFCD22054475
114065-37-1 | 3-(tert-Butyl)-1,2,4-oxadiazol-5-amine | AA009UJE | MFCD11847817
1239648-22-6 | 6-(Trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine | AA009W2B | MFCD11847748
1217516-26-1 | Itraconazole-D9 | AA009W6P | MFCD18711341
1271439-08-7 | (4,8-Bis((2-butyloctyl)oxy)benzo[1,2-b | AA009WN0 | MFCD28144735